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Alzheimer’s disease (AD) is a major neurodegenerative disease and is one of the most
common cause of dementia in older adults. Among several factors, neuroinflammation
is known to play a critical role in the pathogenesis of chronic neurodegenerative
diseases. In particular, studies of brains affected by AD show a clear involvement of
several inflammatory pathways. Furthermore, depending on the brain regions affected
by the disease, the nature and the effect of inflammation can vary. Here, in order to
shed more light on distinct and common features of inflammation in different brain
regions affected by AD, we employed a computational approach to analyze gene
expression data of six site-specific neuronal populations from AD patients. Our network
based computational approach is driven by the concept that a sustained inflammatory
environment could result in neurotoxicity leading to the disease. Thus, our method
aims to infer intracellular signaling pathways/networks that are likely to be constantly
activated or inhibited due to persistent inflammatory conditions. The computational
analysis identified several inflammatory mediators, such as tumor necrosis factor alpha
(TNF-a)-associated pathway, as key upstream receptors/ligands that are likely to transmit
sustained inflammatory signals. Further, the analysis revealed that several inflammatory
mediators were mainly region specific with few commonalities across different brain
regions. Taken together, our results show that our integrative approach aids identification
of inflammation-related signaling pathways that could be responsible for the onset or
the progression of AD and can be applied to study other neurodegenerative diseases.
Furthermore, such computational approaches can enable the translation of clinical omics
data toward the development of novel therapeutic strategies for neurodegenerative
diseases.
Keywords: neuroinflammation, Integrative approach, computational modeling, signaling network, sustained
inflammatory response
INTRODUCTION
Alzheimer’s disease (AD) is one of the most prevalent chronic neurodegenerative disease and
is responsible for 60–70% of cases of dementia, thus laying important healthcare problems in
countries with aging populations (Burns and Iliffe, 2009). Although the precise cause of the disease
is not yet understood, several biochemical and neuropathological studies of brains from individuals
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with AD provide clear evidences for the involvement of
inflammatory pathways (Wyss-Coray and Rogers, 2012). The
neurodegenerative processes during the course of the disease
essentially render neurons unable to fulfill essential functions,
such as signal transmission and network integration in
the central nervous system (CNS), thus affecting essential
daily activities, such as thinking and moving (Burns and
Iliffe, 2009). Importantly, local CNS environment contributes
to neurodegeneration and supportive cells, such as glia
and endothelial cells, are responsible to maintain an ideal
surrounding for neuronal functions (Glass et al., 2010).
Several accumulating evidences suggest that neurodegeneration
occurs in part because the environment is affected during
the disease in a cascade of processes collectively termed
neuroinflammation (Morales et al., 2014; Ransohoff, 2016).
Sustained or chronic inflammation resulting in neuronal death
implies persistence of an inflammatory stimulus or a failure
in normal resolution mechanisms. A persistent stimulus may
result from environmental factors or due to the formation of
endogenous factors, such as protein aggregates, that are perceived
by resident immune cells, e.g., microglia, as “stranger” or
“danger” signals (Glass et al., 2010). Inflammatory responses that
induce autocrine and paracrine neuronal feed-forward/feedback
loops as well as influence the neuronal crosstalk with microglia
and other CNS cell types may hinder normal resolution
mechanisms (Glass et al., 2010; Morales et al., 2014). Although
certain inflammatory stimuli are associated to beneficial effects,
such as phagocytosis of debris and apoptotic cells where
inflammation is linked to beneficial tissue repair processes,
uncontrolled and sustained inflammation may result in the
production of neurotoxic factors that amplify the underlying
disease state (Glass et al., 2010).
The pathological hallmarks of AD in the brain include
extracellular amyloid plaques comprising aggregated, cleaved
products of the amyloid precursor protein (APP) and
intracellular neurofibrillary tangles (NFTs) resulting from
hyperphosphorylation of the microtubule-binding protein
tau (O’Brien and Wong, 2011). Evidence of an inflammatory
response in AD includes changes in microglia morphology—
from ramified (resting) to amoeboid (active)—and astrogliosis
(manifested by an increase in the number, size, and motility
of astrocytes) surrounding the senile plaques (Akiyama et al.,
2000; Liang et al., 2008). Elevation of inflammatory factors
in culture and animal models are known to typically result
in neurodegeneration, and have been reported to be elevated
in pathologically vulnerable regions of the AD brain (Wyss-
Coray and Rogers, 2012). Several existing genetic, cellular, and
molecular changes associated with AD provide clear support for
the role of immune and inflammatory processes in the disease
(Wyss-Coray and Rogers, 2012).
Omics technologies such as, transcriptomics and proteomics,
have enabled the identification of key factors that exhibit
differential expression patterns in disease conditions compared
to homeostatic states (Dendrou et al., 2016). The related
experimental datasets contain rich source of molecular profiles
under different disease conditions. In particular, clinical data
from patients and age-matched controls offer a wealth of
information to be analyzed in order to get insights into the
role of specific deregulated processes involved in the disease
onset and progression (Dendrou et al., 2016). Due to the
recent technological advances, it is now possible to generate and
analyze high-throughput data from numerous individuals, even
down to the level of single cells (Glass et al., 2010; Ransohoff,
2016). However, the enormous complexity of the molecular and
cellular pathways involved in neuroinflammation necessitates
parallel implementation of computational analyses to investigate
pathophysiological mechanisms across different neurological
disorders (Dendrou et al., 2016; Hasin et al., 2017). Means
to translate wealth of clinical omics information into practical
medical benefit is, however, a fundamental challenge that
requires the development and application of novel computational
methods for data analyses and interpretation.
In the context of AD, a significant amount of high-throughput
omics data can be used to further understand the different
deregulated processes that contribute to the disease (Hasin
et al., 2017). Importantly, it has been observed that upregulated
inflammatory mechanisms co-localize in the AD brain with those
regions that exhibit high levels of AD pathology (e.g., frontal
neocortex, limbic cortex) and are absent or minimal in brain
regions with low AD pathologic susceptibility (e.g., cerebellum)
(Akiyama et al., 2000). Furthermore, major efforts have been
directed toward the identification of specific molecular players
of inflammation and their contribution to the disease, but lack
an integrative perspective of common and specific features of
inflammation across different brain regions in AD (Morales et al.,
2014). For this, datasets obtained by tissue or region-specific
molecular profiling of AD post-mortem brain serves as a rich
resource to study and analyze the involvement of inflammation
in different brain regions affected by AD. In this study, in
order to shed more light on neuronal inflammatory signaling
pathways associated with AD, we analyzed publicly available
gene expression data of six different neuronal populations
isolated from post-mortem brains of AD patients. Specifically,
the objective of the current study was to identify region-specific
signaling pathways likely to be involved in inflammation and
how these pathways are distributed across different regions of the
brain affected by AD.
MATERIALS AND METHODS
Rationale
Sustained inflammation resulting in tissue pathology can imply
persistence of an inflammatory stimulus due to failure in normal
clearance mechanisms. A persistent inflammatory stimulus may
result from environmental factors or due to the formation of
endogenous factors, (e.g., protein aggregates) that eventually
cause a sustained activation of certain key intracellular signaling
events in the cognate cells, possibly affecting their homeostatic
states (Figure 1A). Consequently, certain signaling pathways
that were upregulated under normal homeostatic conditions
can get downregulated or inhibited under chronic inflammatory
conditions, and certain pathways originally inhibited or
downregulated under normal conditions can be activated due
to chronic inflammation (Figure 1A). In order to infer such
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FIGURE 1 | Rationale and the schematic of the computational approach employed. (A) Depicts the rationale of the computational network analysis presented in this
study. Cellular microenvironment exerts a constant effect on certain key signaling pathways and maintain them constantly active or inactive. Pathways P1, P2, and P3
denote such constantly activated/inhibited signaling pathways under normal healthy conditions and under chronic inflammation. P2 is a pathway commonly active in
both conditions. However, P1 is active (upregulated) only in healthy microenvironment while it gets inhibited (downregulated) under chronic inflammation. On the other
hand, P3 is activated under chronic inflammation while P1 gets downregulated. The goal in this study is to identify such constantly activated/inhibited signaling
pathways as consequence of inflammation in AD affected in different regions of brain. (B) Represents the overall schematic if the analysis employed in the study.
constantly activated/inhibited signaling pathways/subnetworks
possibly mediated by chronic inflammatory conditions in AD,
we adapted a method that we originally developed to identify
constantly activated/inhibited signaling subnetworks due to
sustained effect of the niche or microenvironment on stem cell
state (Ravichandran et al., 2016; Ravichandran and Del Sol,
2017). Briefly, the methodology combines gene expression data
with signaling interactome, and identifies sparsest signaling
sub-networks by connecting the receptors/ligands with the
transcription factors (TFs) that best explain the differential gene
expression pattern. For this, we assigned differential weights for
interactions (edges) based on expression data and employed a
Prize Collecting Steiner Tree (PCST) algorithm to infer minimal
subgraphs of the signaling interactome (Figure 1B).
Gene Expression Data Sources
Since we were interested in studying the role of chronic
inflammation in different brain regions affected by AD, we
analyzed gene expression datasets obtained from six different
neuronal populations located in different areas of the brain.
Specifically, neuronal populations from entorhinal cortex,
hippocampus, middle temporal gyrus, posterior cingulate cortex,
superior frontal gyrus, and primary visual cortex were collected
(Liang et al., 2008). Gene expression datasets with appropriate
controls are available from the Gene Expression Omnibus (GEO)
with Accession No. GSE5281. The samples consisted of 13
control subjects and 10 AD cases for entorhinal cortex, 13 control
subjects and 10 AD cases for hippocampus, 12 control subjects
and 16 AD cases for middle temporal gyrus, 13 control subjects
and 9 AD cases for posterior cingulate, 11 control subjects and 23
AD cases for superior frontal gyrus, and 12 control subjects and
19 AD cases for primary visual cortex (Liang et al., 2008). Further,
gene expression was profiled by microarray using Affymetrix
Human Genome U133 Plus 2.0 Array platform (Liang et al.,
2008).
Identification and Classification of
Differentially Expressed Genes
We used the lists of differentially expressed genes (DEGs)
directly from the original study (Liang et al., 2008).
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Supplementary Table 1 lists the DEGs for different neuronal
subpopulations used in this study. From the lists of DEGs
specific for different brain regions, we identified a set of
differentially expressed TFs (DETFs) and transcriptional
regulators based on the annotation available at Animal TFDB
(http://bioinfo.life.hust.edu.cn/AnimalTFDB/; Hasin et al.,
2017). For differentially expressed receptors (DERs), since a
complete database of receptor molecules is currently unavailable,
we used Gene Ontology classification of receptor activity and
plasma membrane (GO:0004872, GO:0005886) to identify DEGs
with possible receptor activity. The set of DERs served as the
potential sensors of the environment and, specifically, chronic
inflammatory stimuli. Further, secreted molecules, such as
cytokines and chemokines, can act as regulators of downstream
signaling pathways by activating their cognate receptors. In
order to infer differentially expressed ligands, we took advantage
of the classification of potential ligands reported in a recent
study (Ramilowski et al., 2015). For the purpose of our analysis,
we discretized the expression data based on differential gene
expression and considered genes identified as upregulated and
downregulated (based on the above mentioned cutoff) as “1” and
“−1”, while the non-DEGs were considered “0.” Supplementary
Table 2 contains the classification of the DEGs for different brain
regions.
Compilation of Interactions to Build a
Background Signaling Interactome
In addition to gene expression data, we also required a compiled
list of potential signaling interactions with direction (source-
target relationship) and sign (activation or inhibition) as an input
for our method. For this, we used publicly available signaling
interactions databases OmniPath and ReactomeFI (Wu et al.,
2010; Turei et al., 2016). We combined them by removing the
redundant interactions commonly present in both databases
(by removing the duplicate entry) to acquire only unique
interactions. We chose these two databases as they are well
curated and contain directionality and signs (positive or negative
regulation) of signal flow.
Capturing the Effect of Chronic
Inflammatory Signals
In order to recapitulate the effect of inflammatory signals on the
cells under different diseased conditions, we consider that the
upregulated receptors/ligands for the particular disease are under
direct influence of the diseased environment (or niche). Since
the exact mechanisms of chronic inflammation are not known,
we represent them by introducing a dummy inflammation
node in the raw signaling network. This dummy node is then
connected to all upregulated receptors for each phenotype
under consideration. Therefore, signal transduction from the
inflammatory niche to DETFs must be propagated through at
least one of the upregulated receptors. Such a representation
of unknown external influence by a dummy node has been
applied earlier (Tuncbag et al., 2013). Therefore, according to our
consideration, signal transduction due to inflammation must be
propagated through one of the upregulated receptors in order to
reach the downstream TFs.
Calculation of Differential Edge Weights
The edges in the signaling interactome were weighted using the
gene expression data. This weighting scheme was implemented
in order to maximize the compatibility between the expression
data and interaction sign. By compatible, we mean consistency
between the sign of the interactions (i.e., positive when activating
and negative when inhibiting) and the effect (i.e., activation
or inhibition) that the receptor has on its downstream target
TFs. For example, sign of a signaling path from a receptor to
a TF that is up regulated or overexpressed must be positive
(activation), while it must be negative (inhibition) for down
regulated or under-expressed TF. We calculated the differential
edge weight such that for a given phenotype (for example disease)
it reflected the probability of the target gene of the specific
interaction to be relatively more active when compared to the
other phenotype (for example healthy control) by considering
the interaction sign and booleanized expression state of the
interacting nodes. For example, considering an interaction A
activating B with booleanized expression state of both the nodes
being 1 (upregulated) for first phenotype and consequently −1
(downregulated) for the other phenotype. Here, since both nodes
are upregulated in the first phenotype, the probability of B
being differentially active in first phenotype will be higher in
comparison to the second phenotype where both nodes are
downregulated. However, when we consider an example of A
inhibiting B, the probability of B being differentially active across
the two phenotypes is low, and in such cases we consider
equally low edge weights for the interaction. Since we worked
with booleanized expression values, we considered the fixed
probabilities, where an edge was assigned a probability of 0.9 if
it was classified as high probability interaction and 0.1 when it
was classified as low. Based on such differential edge-weighting
scheme, we calculated differential edge weights for the two
phenotypes under consideration by accounting for interaction
sign and booleanized expression status of the interacting nodes.
Identification of Signaling Subnetworks
In this weighted raw signaling interactome, we aimed to
identify signaling paths that are potentially affected by
chronic inflammation and are responsible for the observed
expression pattern of the DETFs. Our method considers that
microenvironment maintains the cells in a stable state by a
sustained effect on their TFs via constantly activated/inhibited
intracellular signaling pathways compatible with the phenotype-
specific TRN state. The fact that the cells exhibit differences
in their phenotype (diseased vs. healthy) due to differential
effect of the microenvironment suggests that the intracellular
signaling events controlling the specific GRN for maintain the
specific phenotype are also differentially active. For identifying
such signaling sub-networks, we employed PCST formalism
to infer sub-networks with the dummy inflammation node as
the root or origin node and the DETFs as the terminal nodes
employing a heuristic algorithm MSGSTEINER (Bailly-Bechet
et al., 2011). The Steiner Tree formalism have been used earlier to
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reconstruct active signaling pathways (Bailly-Bechet et al., 2011).
Here, the objective is to infer the sparsest sub-networks that
connect the root node (dummy node) and all the terminal nodes
(TFs), that is also compatible with the differential expression
states of the nodes inferred from the data. Since the dummy
node is connected only to the upregulated receptors/ligands, the
inferred sub-networks (Steiner trees) will encompass only those
receptors that are both topologically favorable and compatible
in the expression state to link the DETFs. Therefore, from
several hundreds of upregulated receptors/ligands, we could
narrow down to the few key ones linking the DETFs based on
their unique network topological features. Importantly, as these
sub-networks are more topologically favorable to explain the
downstream gene expression pattern of TFs, they are likely to
represent constantly activated/inhibited signaling sub-networks
due to effect of chronic inflammation. In fact, our computational
approach attempts to infer the sparsest subnetwork that connects
the DERs/ligands and the downstream DETFs, and attempts to
include as many differentially expressed intermediates (linker
molecules) as possible (by maximizing the edge weights) which
are also consistent with the sign of interaction. However,
in cases where there are no such intermediates that are
differentially expressed, certain non-differentially expressed
intermediates are chosen as linker molecules depending on the
network topology. Therefore, these intermediates are necessary
for signal transduction from the DERs/ligands to DETFs.
However, it is important to note that, this does not imply that
differential expression of the downstream genes are caused by the
intermediates that are not differentially expressed. Further, since
we are attempting to capture sustained signaling relying only on
gene expression data, some of the molecules that function via
post-translational modifications are not differentially expressed
but can still act as intermediate linker molecules.
The method infers receptors and associated signaling
subnetworks that are crucial for influencing the DETFs in
a sustained manner, and does not attempt to rank all the
inferred signaling intermediates (other downstream molecules
like associated kinases and phosphatases) or the entire pathway
as a whole.
RESULTS
We employed our computational method to identify signaling
networks that are likely to be constantly perturbed in AD
patients when compared to healthy elderly control individuals.
Here, we discuss certain key receptors and their associated
signaling components that were identified by our method.
Although several of the identified receptors/ligands had a direct
link with inflammatory immune responses, the method also
inferred molecules not directly related to immune responses,
but associated to the disease through other mechanisms. This
could be possibly due to the fact that other processes that
are responsible of AD progression can also exert sustained
influence apart from inflammatory stimuli. Since the method
attempts to infer sustained signaling components, irrespective
of whether they are derived by inflammatory means or any
other process linked to AD, such as deposition of amyloid-
beta (Aβ) plaques or neuronal death, it can therefore gather
components that are not associated to an inflammatory immune
response, but linked to the disease itself. Further, it must be
mentioned that we focused predominantly on characterizing the
region specific inducers (receptors/ligands) of inflammation and
not on all the downstream intermediates and target TFs that
transmit the inflammatory signals based on the inferred signaling
subnetworks. Table 1 lists the receptors/ligands identified for
six different brain regions in the signaling subnetworks with
evidences for their involvement in AD focusing on neuronal
inflammatory immune responses.
In the original study, the analysis was conducted comparing
non-tangle-bearing neurons from AD patients with healthy
neurons from control elderly subjects. In fact, the brain regions
analyzed have been previously observed to show characteristic
pathological differences in the brains of individuals aﬄicted with
AD compared to healthy individuals. The entorhinal cortex and
the hippocampus are two regions that have been found to be
susceptible to early NFT formation (Bouras et al., 1994). The
mid temporal gyrus and the posterior cingulate cortex have been
found to exhibit an elevated susceptibility to amyloid plaque
formation (Blesa et al., 1996). The superior frontal gyrus has
been observed to show metabolic changes relative to normal
aging (Blesa et al., 1996), and the primary visual cortex has been
found to be relatively unaffected from any form of age-related or
disease-related neurodegeneration (Liang et al., 2008). These two
regions are also known to represent late stages of AD (Liang et al.,
2008).
Hippocampus
The hippocampus is critical for learning and memory, is
specifically vulnerable to damage at early stages of AD (Mu
and Gage, 2011). In fact, perturbed neurogenesis in the adult
hippocampus indicates an early critical event in the onset and
progression of AD. From a functional point of view, hippocampal
neurogenesis plays an important role in structural plasticity and
network maintenance (Mu and Gage, 2011). The CA1 region was
selected in the original study (from where the gene expression
data for the computational analysis was obtained) because this
area is the earliest (Braak stages I–IV) and most heavily affected
region of the hippocampus in terms of tangle formation (Liang
et al., 2008).
We identified fibroblast growth factor receptor 1 (FGFR1)
mediated signaling activity as a key upregulated component
in neurons isolated from the hippocampus of AD patients
(Figure 2). FGFR1 signaling is known to transmit inflammatory
signals through regulation of other surface proteins (Woodbury
and Ikezu, 2014). In fact, due to its importance in adult
neurogenesis and neuroinflammation, manipulation of fibroblast
growth factor 2 (FGF2)/FGFR1 signaling has been a focus of
therapeutic development for neurodegenerative disorders, such
as AD, multiple sclerosis (MS), Parkinson’s disease and traumatic
brain injury (Woodbury and Ikezu, 2014). In our sub-network,
FGFR1 signals through CREB binding protein (CREBBP)
induction, a protein involved in the transcriptional co-activation
of many different TFs, such as the inflammatory mediators
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TABLE 1 | Identification of AD specific factors.
Brain region Receptors/ligands identified in the signaling network
Upregulated Positive role in
inflammation/disease
Downregulated Negative role in
inflammation/disease
Hippocampus HMGB1
PPP2CA
SHANK3
FGFR1
GRB2
Yes Yang and Tracey, 2010
Yes Rajendran et al., 2017
PTPRF
ADAM17
HRAS
Yes Qian et al., 2016
Posterior cingulate cortex ADAM10
FGFR1
TNFRSF1A
Yes Rajendran et al., 2017
Yes McAlpine and Tansey,
2008
APP
PTPRE
PTPRD
EPHB6
SORT1
PPP2CA
Yes Carlo et al., 2013
Yes Shanley et al., 2001
Middle temporal gyrus ADAM10
ERBB4
THBS2
ROBO1
EPHB1
NOTCH1
ITPR2
MRC2
EGFR
SDC2
INHBB
Yes Song et al., 2012
Yes Coulthard et al., 2012
Yes Siddiqui et al., 2012
Yes Parish, 2006
TUB
SORT1
TRAF5
CALR
Yes Carlo et al., 2013
Yes Stemmer et al., 2013
Entorhinal cortex ERBB3
EGFR
PLXNA2
FGFR1
IGF1R
FN1
ERBB4
LIFR
TNFRSF1A
Yes Siddiqui et al., 2012
Yes Lin et al., 2009
Yes Rajendran et al., 2017
Yes Blazquez et al., 2014
Yes Song et al., 2012
Yes Pan et al., 2008
Yes McAlpine and Tansey,
2008
GNAS
LRPAP1
CHRNA7
EPHA4
PTPRR
IL12RB2
CHRNB2
GNAI2
TRAF5
PRKCE
MST1
GPC1
SHC1
Yes Pandey et al., 2008
Yes Dineley, 2007
Yes Rosenberger et al.,
2014
Primary visual cortex EGFR
FGFR1
ROBO1
Yes Siddiqui et al., 2012
Yes Rajendran et al., 2017
CNTN1
PPP2CA
ERBB4
Yes Shanley et al., 2001
Superior frontal gyrus EGFR Yes Siddiqui et al., 2012 PPP2CA
BDNF
Yes Shanley et al., 2001
Yes Jiao et al., 2016
interferon regulatory factor 1 (IRF1) and E2F transcription
factor 1 (E2F1), the latest involved in the modulation of
neuronal apoptosis (Hou et al., 2000). High mobility group
box 1 (HMGB1) is a mediator of inflammation that is released
extracellularly during cells death or secreted by activated cells
(Jiao et al., 2016). In line with its involvement in inflammatory
processes, HMGB1 upregulation in our sub-network is linked to
tumor protein p53 (TP53) and nuclear factor kappa b subunit 1
(NFKB1), two main inflammatory signaling pathways.
Among the downregulated receptors, ADAM
metallopeptidase domain 17 (ADAM17), a metalloprotease
involved in the processing of tumor necrosis factor alpha (TNF)
that has been described to counteract inflammation and further
neuronal damage, was identified (Figure 2; Qian et al., 2016).
Posterior Cingulate Cortex
The precise function of the posterior cingulate cortex is not
yet clearly established. However, it is known to be involved in
cognitive tasks (Leech et al., 2012). This region is known to
acquire early amyloid deposition, reduced metabolism in AD
(Leech and Sharp, 2014), and therefore serves as a key region to be
studied despite the lack of clarity in its functionality in the brain.
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FIGURE 2 | Key signaling networks identified for the hippocampus. The figure shows three key signaling subnetworks controlled by FGFR1, HMGB1, and ADAM17
identified for hippocampus with known role in AD. FGFR1 mediated subnetwork was found to control of 23 up- and 6 downregulated TFs, HMGB1 mediated
pathways controlled 3 upregulated and 4 downregulated TFs, and ADAM17 controlled 2 downregulated TFs. Further, FGFR1 and HMGB1 represent constantly
activated signaling subnetworks while ADAM17 represent constantly inhibited signaling pathways. Inverted triangles denote receptor/ligand molecules, circular nodes
represent signaling intermediates, and square nodes represent transcription factors. Any node that is not a TF or a receptor/ligand is considered a signaling
intermediate such as kinases/phosphatases and adapter molecules. The edges with arrowhead denote activation and those with dashed head denote inhibitory
interactions. Green nodes indicate upregulated genes in hippocampus region of AD brain, while the red nodes indicate downregulated ones. Blue nodes represent
those intermediates that are not differentially expressed but serve to link the differentially expressed receptor/ligand to the downstream TFs. Supplementary Figure 1
contains the other subnetworks identified for hippocampus that did not have known role in AD.
TNF receptor superfamily member 1 (TNFRSF1A), a known
pro-inflammatory signaling component, was a major player in
the posterior cingulate cortex sub-network (Figure 3). Excess
of inflammatory mediators in the brain are associated, at least
partly, to activatedmicroglia, which accumulate around amyloid-
beta (Aβ) plaques in AD brains, showing chronic activation
and therefore signaling constantly. Elevated levels of pro-
inflammatory cytokines, such as TNF, could potentially inhibit
phagocytosis of Aβ in AD brains thereby hindering efficient
plaque removal by resident microglia (McAlpine and Tansey,
2008). Moreover, FGFR1, also upregulated in the hippocampal
neurons from AD patients, was identified in the posterior
cingulate cortex region.
Among the downregulated signaling networks, we identified
sortilin 1 (SORT1), a pro-neurotrophin receptor which plays
a major role in the clearance of apolipoprotein E (APOE)/Aβ
complexes in neurons (Figure 3; Carlo et al., 2013). APOE
sequesters neurotoxic Aβ peptides and deliver them for cellular
catabolism via neuronal APOE receptors (Carlo et al., 2013).
SORT1 binds APOE with high affinity and lack of receptor
expression in mice results in accumulation of APOE and Aβ
in the brain and in aggravated plaque burden, thus suggesting
a link between Aβ catabolism and pro-neurotrophin signaling
converging to this receptor (Carlo et al., 2013). Another receptor
identified in the network was protein phosphatase 2 catalytic
subunit alpha (PPP2CA). It binds to tau and is the primary
tau phosphatase (Sontag and Sontag, 2014). Its deregulation
correlates with increased tau phosphorylation likely contributing
to tau deregulation in AD (Sontag and Sontag, 2014). The
signaling network controlled by SORT1 was also inferred in the
middle temporal gyrus network, while PPP2CA was inferred in
the superior frontal gyrus network (Table 1), thereby implicating
their role in other affected brain regions.
Middle Temporal Gyrus
This brain region is known to be involved in cognitive processes
including, language and semantic memory processing, visual
perception, and multimodal sensory integration (Onitsuka et al.,
2004). Further, the middle temporal gyrus is known to exhibit
reduced metabolic activity in AD (Liang et al., 2008).
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FIGURE 3 | Key signaling networks identified for the posterior cingulate cortex. The figure shows four key signaling subnetworks controlled by TNFRSF1A, FGFR1,
SORT1, and PPP2CA identified for posterior cingulate cortex with known role in AD. TNFRSF1A mediated subnetwork consisted of 15 up and 12 down regulated
TFs, FGFR1 mediated subnetwork consisted of 8 up- and 6 downregulated TFs, SORT1 mediated subnetwork consisted of 4 up- and 6 downregulated TFs and
PPP2CA mediated subnetwork consisted of 15 up- and 13 downregulated TFs. TNFRSF1A and FGFR1 controlled subnetworks represent constantly activated
signaling subnetworks while SORT1 and PPP2CA subnetworks represent constantly inhibited ones. The figure legends are the same as that in Figure 2.
Supplementary Figure 2 contains the other subnetworks identified for posterior cingulate cortex that did not have known role in AD.
Syndecan 2 (SDC2) and ERB-B2 receptor tyrosine kinase 4
(ERRB4) mediated signaling were identified in our sub-networks
to play key roles in the middle temporal gyrus area (Table 1;
Figure 4). In addition, we found Notch1 mediated signaling to
be crucial in that region. Notch1 signaling is essential for various
CNS functioning from brain development to adult brain function
(Brai et al., 2016). Reduction in Notch1 expression affects
synaptic plasticity, memory and olfaction. On the contrary,
Notch1 over-activation after brain injury is detrimental for
neuronal survival (Brai et al., 2016). Some familial AD mutations
in presenilins can affect Notch1 processing/activation (Brai
et al., 2016). Further reports described Notch1 overexpression in
sporadic AD.
In the downregulated signaling networks, calreticulin (CALR)
and its downstream network was identified by our method
(Figure 4). Calreticulin is found in a complex with APP and Aβ
and levels of the calreticulin mRNA and protein are reduced in
patients with AD. This suggests that calreticulin is implicated in
the proteolytic processing of APP and, thus, in AD pathogenesis
(Stemmer et al., 2013).
Entorhinal Cortex
The entorhinal cortex is thought to be a major input and output
structure of the hippocampal formation, acting as the nodal
point of cortico-hippocampal circuits (Canto et al., 2008). This
is one of the most vulnerable brain regions that is attacked
during the early stages of AD (Van Hoesen et al., 1991) and
is thought to spread from here to other regions of brain.
Further, there are emerging roles of inflammation in promoting
neurodegeneration in the entorhinal cortex (Criscuolo et al.,
2017).
Epidermal growth factor receptor (EGFR)-mediated
signaling was identified as a key upregulated component of
the entorhinal cortical neurons isolated from AD patients
compared to healthy subjects (Figure 5). Although EGFR is
not directly implicated in neuroinflammation, it is known
to play a central role in neurometabolic aging. EGFR acts as
a signaling entity for several ligand mediated mechanisms
and cellular stress responses directly related to aging and
degeneration (Siddiqui et al., 2012). Further, EGFR signaling
has been implicated in a spectrum of neurometabolic
conditions, such as metabolic syndrome, diabetes, AD,
cancer, and cardiorespiratory function (Siddiqui et al.,
2012). More recently, it has been observed that inhibition
of EGFR enables rescue of memory loss in both mouse and
drosophila.
LDL receptor related protein associated protein 1 (LRPAP1)
and its downstream signaling network was found to be
downregulated in this brain region (Figure 5). Interestingly,
LRPAP1 levels have been found to be low in patients
with increased susceptibility to AD, which implicates a
link of this receptor with Aβ clearance. Co-localization
of Aβ, APOE and LRPAP1 on senile plaques suggests its
involvement in the clearance of APOE/Aβ complex (Pandey
et al., 2008). In recent years, the lipoprotein receptor low-
density lipoprotein receptor-related protein 1 (LRP1), the down-
stream effector of LRPAP1 in our sub-network, emerged as
an important regulator of the inflammatory response (May,
2013).
Frontiers in Physiology | www.frontiersin.org 8 March 2018 | Volume 9 | Article 154
Ravichandran et al. Integrative Computational Analysis for AD
FIGURE 4 | Key signaling networks identified for the middle temporal gyrus. The figure shows five key signaling subnetworks controlled by EGFR, SDC2, ERBB4,
EPHB1, SORT1, and CALR for middle temporal gyrus with known role in AD. EGFR controlled subnetwork consisted of 39 up- and 15 downregulated TFs, SDC2
subnetwork consisted of 39 up- and 12 downregulated TFs, ERBB4 subnetwork consisted of 9 up- and 3 downregulated TFs, EPHB1 subnetwork consisted of 2 up-
and 2 downregulated TFs, SORT1 consisted of 2 up- and 4 downregulated TFs, CALR consisted of one downregulated TF. Further, subnetworks controlled by EGFR,
SDC2, ERBB4, EPHB1 represent constantly activated signaling while the ones controlled by SORT1 and CALR represent constantly inhibited signaling pathways. The
figure legends are the same as that in Figure 2. Supplementary Figure 3 contains the other subnetworks identified for middle temporal gyrus that did not have known
role in AD.
Primary Visual Cortex and Superior Frontal
Gyrus
The primary function of the early visual cortex is visual
perception (Petro et al., 2017) and the superior frontal gyrus
is thought to contribute to higher cognitive functions, in
particularly to working memory (du Boisgueheneuc et al., 2006).
These two brain regions have been included in the original
study as they are known to be later (Braak stages V and VI)
and less affected by the disease, and consist of least number of
DEGs among the analyzed brain regions (Supplementary Table
1). The major signaling pathway upregulated in these two regions
involved EGFR in both areas and FGFR1 in the primary visual
cortex. These receptors were also identified by our analysis in
other affected brain regions (Table 1; Figure 6).
Among the downregulated effectors, the phosphatase
PPP2CA, already identified as decreased in the posterior
cingulate cortex and upregulated in the hippocampus, was
identified in both areas. Furthermore, we found brain-derived
neurotrophic factor (BDNF) and its downstream signaling to
be specifically downregulated in the superior frontal gyrus area
(Figure 7). Importantly, BDNF is known to protect against
tau-related neurodegeneration in Alzheimer’s disease (Jiao et al.,
2016).
Brain Regions Sharing Common
Inflammatory Mediators
After identifying the signaling sub-networks likely to
be constantly activated/inhibited in different neuronal
subpopulations of AD affected brain, we identified the common
and specific factors among different brain regions. As it could
be seen from Figure 8, only few identified factors were shared
across different brain regions, while the majority of the factors
were specific for the respective brain region. Notably, EGFR
signaling was identified to be active for four regions, namely,
middle temporal gyrus, entorhinal cortex, primary visual cortex
and superior frontal gyrus. In fact, recent studies in AD mouse
models have observed that EGFR is a preferred target for treating
Aβ-induced memory loss, adding value to our computational
inference (Wang et al., 2012). Another key receptor found to be
commonly active in posterior cingulate cortex and entorhinal
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FIGURE 5 | Key signaling networks identified for the entorhinal cortex. The figure shows ten key signaling subnetworks controlled by EGFR, IGF1R, CHRNA7, FGFR1,
EPHA4, TNFRSF1A, PLXNA2, LIFR, LRPAP1, and ERRB4 identified for entorhinal cortex with known role in AD. The signaling subnetworks controlled by EGFR,
IFG1R, FGFR1, TNFRS1A, PLZNA2, LIFR, and ERBB4 represent constantly activated signaling, while the ones controlled by CHRNA7, EPHA4, and LRPAP1
represent constantly inhibited ones. Further, EGFR subnetwork was found regulate most of the differentially expressed TFs by controlling 16 upregulated and 12
downregulated TFs. The figure legends are the same as that in Figure 2. Supplementary Figure 4 contains the other subnetworks identified for entorhinal cortex that
did not have known role in AD.
cortex is TNFRSF1A, which is a well-known pro-inflammatory
factor (Carlo et al., 2013). More importantly, blocking TFN
signaling either via genetic manipulation or using chemical
inhibitors, reduced the accumulation of intraneuronal amyloid-
associated proteins triggered by chronic systemic inflammation,
and could possibly act as a valid therapeutic target to modify
disease progression during the early stages of AD (McAlpine
et al., 2009). FGFR1 mediated signaling pathway, which is known
to have profound roles in neurogenesis, was found to be present
in entorhinal cortex, hippocampus and primary visual cortex
(Woodbury and Ikezu, 2014). Further, activation of this signaling
by FGF2 has proven to be highly efficient for the regeneration
of neurons in multiple experimental animal models (Woodbury
and Ikezu, 2014). In fact, several groups have shown the potential
use of FGF2 as a therapeutic for neurodegenerative conditions
including AD and PD. FGF2 gene transfer in AD transgenic
mouse models is known to significantly restore spatial learning,
hippocampal CA1 long-term potentiation, and neurogenesis in
the SGZ (Kiyota et al., 2011). Another active signaling pathway
commonly present in middle temporal gyrus and primary visual
cortex were mediated by ADAM10 and this signaling has known
roles in AD (Yuan et al., 2017).
In the case of inhibited signaling pathways (Table 1), only
SORT1 and PPP2CA were identified to be commonly present
in multiple brain regions. SORT1 was present in the middle
temporal gyrus and primary visual cortex, and this molecule has
recently been found to act as a novel receptor for apolipoprotein
E (APOE) (Carlo, 2013; Carlo et al., 2013). Importantly, ablation
of sortilin expression in mice results in accumulation of APOE
and Aβ in the brain resulting in AD like physiology the mice
(Carlo, 2013). PPP2CA was another key inhibited signaling
identified to be present in three different brain regions namely,
posterior cingulate cortex, primary visual cortex and superior
frontal gyrus. Alterations in this phosphatase activity have been
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FIGURE 6 | Key signaling networks identified for the primary visual cortex. The figure shows three signaling subnetworks controlled by EGFR, FGFR, and PPP2CA for
the primary visual cortex with known role in AD. EGFR signaling subnetwork was found to regulate 20 up- and 21 downregulated TFs, FGFR signaling subnetwork
was found to regulate 13 up- and 12 downregulated TFs, and PPP2CA signaling subnetwork was found to regulate 9 up- and 4 downregulated TFs. Further, EGFR
and FGFR1 subnetworks were found to be constantly activated while PPP2CA signaling subnetwork was constantly inhibited. The figure legends are the same as that
in Figure 2. Supplementary Figure 5 contains the other subnetworks identified for primary visual cortex that did not have known role in AD.
reported in AD-affected brain regions and has been linked to
tau hyperphosphorylation, amyloidogenesis and synaptic deficits
(Sontag and Sontag, 2014).
DISCUSSION
Technical advancements in sequencing allow the analysis
of thousands of molecular profiles from clinical samples
with high quality. These high-throughput techniques open-up
opportunities for the development of computational analysis
tools to infer meaningful patterns from big data. In this study,
we have analyzed gene expression profiling data of specific
neuronal populations collected by laser capture microdissection
from postmortem samples of AD patients with the aim of
identifying brain region specific signaling subnetworks affected
by chronic inflammation. The network analysis we carried
out enabled the identification of a fraction of receptor/ligands
(and the associated downstream signaling networks) as key
inflammatory mediators from a large number of DERs and
ligands. In fact, on average, there were about 100 DERs/ligand
molecules in the datasets we analyzed, and our method
was able to identify crucial inflammation mediators. This
highlights the utility of network approaches to refine and
extract accurate and relevant information from high-throughput
datasets. Furthermore, computational analyses are amenable to
consider more than one diseased region simultaneously and
therefore can be used to evaluate the commonalities and distinct
features of regulatory processes involved in different regions
in an integrative manner. In addition, when data are available,
approaches like ours can be employed to study differences and
commonalities of a specific disease phenotype in the context of
different regions or tissues that are affected due the disease.
EGFR is one of the key molecule identified from our analysis
to be common for four different regions namely, middle temporal
gyrus, entorhinal cortex, primary visual cortex and superior
frontal cortex of AD brain. Importantly, recent evidences suggest
a crucial role for EGFR in AD pathogenesis, where potential
interactions between Aβ oligomers and EGFR were found (Wang
et al., 2012). Furthermore, inhibition of EGFR led to reversal of
memory loss in AD mouse models (Wang et al., 2012). Notably,
brain regions known to be less affected by AD, such as primary
visual cortex and superior frontal gyrus, contained lesser number
of sub-networks compared to regions highly perturbed by the
disease, such as entorhinal cortex and middle temporal gyrus.
This probably suggests that changes in AD brains are more
pronounced in the main affected areas when compared to less
influenced regions. This feature could also be partly attributed
to the less number of DEGs in these two regions of AD brain
(Supplementary Table 1). Despite the lower number of DEGs in
the primary visual cortex and the superior frontal gyrus, EGFR
was found to be crucial in these two regions in addition to its
role in the middle temporal gyrus and the entorhinal cortex.
This could also possibly reflect a crucial role for EGFR in the
progression of AD in both early and late stages of the disease.
It has to be mentioned that EGFR was not upregulated in two
other important regions, i.e., the hippocampus and the posterior
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FIGURE 7 | Key signaling networks identified for the superior frontal gyrus. The figure shows three signaling subnetworks controlled by EGFR, PPP2CA, and BDNF
for the superior frontal gyrus with known role in AD. EGFR signaling subnetwork was found to be constantly activated and controlled 7 up- and 11 downregulated TFs.
PPP2CA and BDNF were found to be constantly inhibited signaling subnetworks. PPP2CA was found to regulate 7 up- and 5 downregulated TFs, while BDNF was
found to regulate 1 up- and 3 downregulated TFs. The figure legends are the same as that in Figure 2.
cingulate cortex at least in the dataset we analyzed. It could
possibly reflect region specific perturbation of key molecules and
it also might relate to the fact that EGFR can also be regulated
post-translationally and not always at the gene expression level.
Our computational analysis of AD samples from six different
brain regions identified certain common regulators, such as
FGFR1 and PPP2CA, known to be key neuroinflammatory
factors (Tuncbag et al., 2013; Rajendran et al., 2017). In addition,
certain region specific factors, such as CALR and EPHB1 in the
middle temporal gyrus, were also identified by our analysis. In
addition to several receptor/ligand molecules with direct role in
inflammation, our analysis identified several novel candidates
whose direct link to inflammation and the disease is not
clearly known. For instance, we identified the Notch receptor,
NOTCH1, in the middle temporal gyrus network. Although
this receptor is not directly related to neuroinflammation, the
role of Notch signaling pathway in promoting pro-inflammatory
responses in the cells expressing NOTCH1 has been observed
(Brai et al., 2016). Such molecules with no direct evidences in
inflammation are novel predictions from our analysis, and will be
interesting to experimentally test if they are important to transmit
inflammatory signaling in these disease conditions.
Overall, our analysis revealed mostly distinct and few
common inflammatory signaling components across the
different neuronal populations analyzed. However, despite
the predominance of region specific factors, the analysis
identified certain shared inflammatory factors, reflecting some
environmental similarities across the affected brain regions,
such as the presence of Aβ plaques. Further, we observed that
not all receptors/ligands that were identified by our analyses
were directly related to inflammation, but were known to
be implicated in the disease via some other processes, such
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FIGURE 8 | Characterization of common and unique region specific inflammatory regulators in AD brain inferred from the computational analysis. The figure shows
the Venn diagram comparing the inferred regulators of inflammation (A) upregulated in AD, and (B) downregulated in AD, for four major regions AD patients analyzed
in this study. These regions are hippocampus (HIP), posterior cingulate cortex (PC), middle temporal gyrus (MTG) and entorhinal cortex (EC). Regulators (only
considering receptors/ligands) found to be important for more than one brain regions are highlighted in the box. In addition, in the case of upregulated signaling
subnetworks, EGFR signaling was identified for primary visual cortex and superior frontal gyrus in addition to its role in middle temporal gyrus and entorhinal cortex,
and FGFR1 signaling was identified for primary visual cortex. In the case of downregulated signaling subnetworks, PPP2CA was found to be commonly present in
primary visual cortex and superior frontal gyrus.
as metabolic dysregulation (for example, SORT1). This is
because, although we considered inflammation to be one of
the predominant cause of sustained signaling activities, our
computational approach infers constantly activated/inhibited
signaling pathways irrespective of whether these pathways
are induced by inflammation or any other cellular processes.
Although this aspect could represent a limitation of our
approach, it rather demonstrates that it can be applied in
cases where sustained signaling pathways need to be identified
(Ravichandran et al., 2016; Ravichandran and Del Sol, 2017).
Further, certain classical inflammatory mediators, such as
FAS- and IL6-related pathways, were not identified. This could
be explained by the fact that our approach requires that the
modulation of the factors has to occur at gene expression level,
and that our approach does not take into account specific
receptors and TFs that are not differentially expressed under
the disease condition. However, these mediators can still be
active during inflammatory processes, for instance via post
translation modifications, and our approach cannot detect such
mediators since it currently relies only on mRNA level changes.
In general, these limitations can be addressed when we consider
proteomics or phosphoproteomics datasets for the inference
of sustained signaling. However, availability of such protein
level datasets are still limited compared to transcriptomics
datasets and despite such limitations, predominantly due to
incomplete data, we observed that our computational approach
revealed the involvement of several disease related pro- and anti-
inflammatory factors highlighting the value of such analysis.
To our knowledge, this is one of the first study, which
computationally analyzed the potential implication of
chronic inflammation on AD to infer the induced signaling
networks/pathways. In this regard, it must be mentioned that
two recent studies have attempted to infer common and unique
pathways/signatures in different neurodegenerative diseases (Li
et al., 2014, 2015). However, their focus was more on “generic”
pathways affected due to the disease and not specifically related to
inflammation or sustained signaling. Further, in both studies, the
analysis was predominantly based on differential gene expression
signatures and pathway enrichment, and did not attempt to
capture dysregulated network components as described in our
study (Li et al., 2014, 2015). Although these studies are very
useful to understand the overall pathways that are dysregulated
in the disease condition and to define disease signatures, they
do not capture specific molecular features that can relate the
pathways to the disease itself. Alternatively, our analysis focus on
inference of sustained signaling subnetworks to capture specific
molecular features of chronic inflammation, which was not the
focus of the other studies. Consequently, our current analysis
revealed specific factors that were up- or down- regulated in
neuronal populations from different brain regions affected by
AD that were implicated in inflammation and the disease.
In the context of neurodegenerative diseases, integrative
approaches enable to obtain a holistic understanding of
the processes and factors that initiate and sustain specific
disease pathologies that act primarily at the cellular level.
For instance, protective and pathogenic roles of glial cells,
such as microglia and astrocytes, in addition to the activation
of common inflammatory pathways in these cells in several
neurodegenerative diseases, support the concept that glia-
induced inflammation can possibly sustain the disease pathology
(Burns and Iliffe, 2009; Wyss-Coray and Rogers, 2012). In
this context, integrative computational approaches like ours
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enable the identification of factors whose perturbation (by either
activating or inhibiting) could reduce the production of factors
that contribute to neurotoxicity, thereby potentially resulting in
clinical benefit in specific neurodegenerative diseases.
AUTHOR CONTRIBUTIONS
SR and AdS conceived the idea. SR performed the computational
analysis. All authors contributed to the writing of the manuscript
and approved the final version of the manuscript. AdS
coordinated the overall project.
ACKNOWLEDGMENTS
The authors would like to acknowledge the funding from
University of Luxembourg, for ASTROSYS (R-AGR-3227)
Internal Research Project (IRP grant).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fphys.
2018.00154/full#supplementary-material
REFERENCES
Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., et al.
(2000). Inflammation and Alzheimer’s disease. Neurobiol. Aging 21, 383–421.
doi: 10.1016/S0197-4580(00)00124-X
Bailly-Bechet, M., Borgs, C., Braunstein, A., Chayes, J., Dagkessamanskaia, A.,
Francois, J. M., et al. (2011). Finding undetected protein associations in cell
signaling by belief propagation. Proc. Natl. Acad. Sci. U.S.A. 108, 882–887.
doi: 10.1073/pnas.1004751108
Blazquez, E., Velazquez, E., Hurtado-Carneiro, V., and Ruiz-Albusac, J. M. (2014).
Insulin in the brain: its pathophysiological implications for States related
with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front.
Endocrinol. (Lausanne). 5:161. doi: 10.3389/fendo.2014.00161
Blesa, R., Mohr, E., Miletich, R. S., Hildebrand, K., Sampson, M., and Chase, T.
N. (1996). Cerebral metabolic changes in Alzheimer’s disease: neurobehavioral
patterns. Dementia 7, 239–245. doi: 10.1159/000106886
Bouras, C., Hof, P. R., Giannakopoulos, P., Michel, J. P., and Morrison, J. H.
(1994). Regional distribution of neurofibrillary tangles and senile plaques in
the cerebral cortex of elderly patients: a quantitative evaluation of a one-
year autopsy population from a geriatric hospital. Cereb. Cortex 4, 138–150.
doi: 10.1093/cercor/4.2.138
Brai, E., Alina Raio, N., and Alberi, L. (2016). Notch1 hallmarks fibrillary
depositions in sporadic Alzheimer’s disease. Acta Neuropathol. Commun. 4:64.
doi: 10.1186/s40478-016-0327-2
Burns, A., and Iliffe, S. (2009). Alzheimer’s disease. BMJ 338:b158.
doi: 10.1136/bmj.b158
Canto, C. B., Wouterlood, F. G., and Witter, M. P. (2008). What does the
anatomical organization of the entorhinal cortex tell us? Neural Plast.
2008:381243. doi: 10.1155/2008/381243
Carlo, A. S. (2013). Sortilin, a novel APOE receptor implicated in Alzheimer
disease. Prion 7, 378–382. doi: 10.4161/pri.26746
Carlo, A. S., Gustafsen, C., Mastrobuoni, G., Nielsen, M. S., Burgert, T.,
Hartl, D., et al. (2013). The pro-neurotrophin receptor sortilin is a major
neuronal apolipoprotein E receptor for catabolism of amyloid-beta peptide
in the brain. J. Neurosci. 33, 358–370. doi: 10.1523/JNEUROSCI.2425-
12.2013
Coulthard, M. G., Morgan, M., Woodruff, T. M., Arumugam, T. V., Taylor,
S. M., Carpenter, T. C., et al. (2012). Eph/Ephrin signaling in injury and
inflammation. Am. J. Pathol. 181, 1493–1503. doi: 10.1016/j.ajpath.2012.
06.043
Criscuolo, C., Fontebasso, V., Middei, S., Stazi, M., Ammassari-Teule, M., Yan,
S. S., et al. (2017). Entorhinal cortex dysfunction can be rescued by inhibition
of microglial RAGE in an Alzheimer’s disease mouse model. Sci. Rep. 7:42370.
doi: 10.1038/srep42370
Dendrou, C. A., McVean, G., and Fugger, L. (2016). Neuroinflammation -
using big data to inform clinical practice. Nat. Rev. Neurol. 12, 685–698.
doi: 10.1038/nrneurol.2016.171
Dineley, K. T. (2007). Beta-amyloid peptide–nicotinic acetylcholine receptor
interaction: the two faces of health and disease. Front. Biosci. 12, 5030–5038.
doi: 10.2741/2445
du Boisgueheneuc, F., Levy, R., Volle, E., Seassau, M., Duffau, H., Kinkingnehun,
S., et al. (2006). Functions of the left superior frontal gyrus in humans: a lesion
study. Brain 129, 3315–3328. doi: 10.1093/brain/awl244
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H.
(2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140,
918–934. doi: 10.1016/j.cell.2010.02.016
Hasin, Y., Seldin, M., and Lusis, A. (2017). Multi-omics approaches to disease.
Genome Biol. 18:83. doi: 10.1186/s13059-017-1215-1
Hou, S. T., Callaghan, D., Fournier, M. C., Hill, I., Kang, L., Massie, B., et al. (2000).
The transcription factor E2F1 modulates apoptosis of neurons. J. Neurochem.
75, 91–100. doi: 10.1046/j.1471-4159.2000.0750091.x
Jiao, S. S., Shen, L. L., Zhu, C., Bu, X. L., Liu, Y. H., Liu, C. H., et al. (2016). Brain-
derived neurotrophic factor protects against tau-related neurodegeneration of
Alzheimer’s disease. Transl. Psychiatry 6:e907. doi: 10.1038/tp.2016.186
Kiyota, T., Ingraham, K. L., Jacobsen, M. T., Xiong, H., and Ikezu, T. (2011). FGF2
gene transfer restores hippocampal functions in mouse models of Alzheimer’s
disease and has therapeutic implications for neurocognitive disorders.
Proc. Natl. Acad. Sci. U.S.A. 108, E1339–E1348. doi: 10.1073/pnas.11023
49108
Leech, R., Braga, R., and Sharp, D. J. (2012). Echoes of the brain
within the posterior cingulate cortex. J. Neurosci. 32, 215–222.
doi: 10.1523/JNEUROSCI.3689-11.2012
Leech, R., and Sharp, D. J. (2014). The role of the posterior cingulate cortex in
cognition and disease. Brain 137, 12–32. doi: 10.1093/brain/awt162
Li, M. D., Burns, T. C., Morgan, A. A., and Khatri, P. (2014). Integrated
multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta
Neuropathol. Commun. 2:93. doi: 10.1186/s40478-014-0093-y
Li, P., Nie, Y., and Yu, J. (2015). An effective method to identify shared
pathways and common factors among neurodegenerative diseases. PLoS ONE
10:e0143045. doi: 10.1371/journal.pone.0143045
Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K.,
et al. (2008). Altered neuronal gene expression in brain regions differentially
affected by Alzheimer’s disease: a reference data set. Physiol. Genomics 33,
240–256. doi: 10.1152/physiolgenomics.00242.2007
Lin, L., Lesnick, T. G., Maraganore, D. M., and Isacson, O. (2009). Axon guidance
and synaptic maintenance: preclinical markers for neurodegenerative disease
and therapeutics. Trends Neurosci. 32, 142–149. doi: 10.1016/j.tins.2008.11.006
May, P. (2013). The low-density lipoprotein receptor-related
protein 1 in inflammation. Curr. Opin. Lipidol. 24, 134–137.
doi: 10.1097/MOL.0b013e32835e809c
McAlpine, F. E., Lee, J. K., Harms, A. S., Ruhn, K. A., Blurton-Jones, M.,
Hong, J., et al. (2009). Inhibition of soluble TNF signaling in a mouse
model of Alzheimer’s disease prevents pre-plaque amyloid-associated
neuropathology. Neurobiol. Dis. 34, 163–177. doi: 10.1016/j.nbd.2009.
01.006
McAlpine, F. E., and Tansey,M. G. (2008). Neuroinflammation and tumor necrosis
factor signaling in the pathophysiology of Alzheimer’s disease. J. Inflamm. Res.
1, 29–39. doi: 10.2147/JIR.S4397
Morales, I., Guzman-Martinez, L., Cerda-Troncoso, C., Farias, G. A., and
Maccioni, R. B. (2014). Neuroinflammation in the pathogenesis of Alzheimer’s
Frontiers in Physiology | www.frontiersin.org 14 March 2018 | Volume 9 | Article 154
Ravichandran et al. Integrative Computational Analysis for AD
disease. A rational framework for the search of novel therapeutic approaches.
Front Cell Neurosci 8:112. doi: 10.3389/fncel.2014.00112
Mu, Y., and Gage, F. H. (2011). Adult hippocampal neurogenesis and its role in
Alzheimer’s disease.Mol. Neurodegener. 6:85. doi: 10.1186/1750-1326-6-85
O’Brien, R. J., and Wong, P. C. (2011). Amyloid precursor protein
processing and Alzheimer’s disease. Annu. Rev. Neurosci. 34, 185–204.
doi: 10.1146/annurev-neuro-061010-113613
Onitsuka, T., Shenton, M. E., Salisbury, D. F., Dickey, C. C., Kasai, K., Toner,
S. K., et al. (2004). Middle and inferior temporal gyrus gray matter volume
abnormalities in chronic schizophrenia: an MRI study. Am. J. Psychiatry 161,
1603–1611. doi: 10.1176/appi.ajp.161.9.1603
Pan, W., Yu, C., Hsuchou, H., Zhang, Y., and Kastin, A. J. (2008).
Neuroinflammation facilitates LIF entry into brain: role of TNF. Am. J. Physiol.
Cell Physiol. 294, C1436–C1442. doi: 10.1152/ajpcell.00489.2007
Pandey, P., Pradhan, S., and Mittal, B. (2008). LRP-associated protein gene
(LRPAP1) and susceptibility to degenerative dementia. Genes Brain Behav. 7,
943–950. doi: 10.1111/j.1601-183X.2008.00436.x
Parish, C. R. (2006). The role of heparan sulphate in inflammation. Nat. Rev.
Immunol. 6, 633–643. doi: 10.1038/nri1918
Petro, L. S., Paton, A. T., and Muckli, L. (2017). Contextual modulation of primary
visual cortex by auditory signals. Philos. Trans. R. Soc. Lond. B Biol. Sci.
372:20160104. doi: 10.1098/rstb.2016.0104
Qian, M., Shen, X., and Wang, H. (2016). The distinct role of ADAM17 in APP
proteolysis and microglial activation related to Alzheimer’s Disease. Cell. Mol.
Neurobiol. 36, 471–482. doi: 10.1007/s10571-015-0232-4
Rajendran, R., Giraldo-Velasquez, M., Stadelmann, C., and Berghoff, M. (2017).
Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects
mice from experimental autoimmune encephalomyelitis through ERK/AKT
phosphorylation. Brain Pathol. doi: 10.1111/bpa.12487. [Epub ahead of print].
Ramilowski, J. A., Goldberg, T., Harshbarger, J., Kloppmann, E., Lizio, M.,
Satagopam, V. P., et al. (2015). A draft network of ligand-receptor-
mediated multicellular signalling in human. Nat. Commun. 6:7866.
doi: 10.1038/ncomms8866
Ransohoff, R. M. (2016). How neuroinflammation contributes to
neurodegeneration. Science 353, 777–783. doi: 10.1126/science.aag2590
Ravichandran, S., and Del Sol, A. (2017). Identifying niche-mediated regulatory
factors of stem cell phenotypic state: a systems biology approach. FEBS Lett.
591, 560–569. doi: 10.1002/1873-3468.12559
Ravichandran, S., Okawa, S., Martinez Arbas, S., and Del Sol, A. (2016). A systems
biology approach to identify niche determinants of cellular phenotypes. Stem
Cell Res. 17, 406–412. doi: 10.1016/j.scr.2016.09.006
Rosenberger, A. F., Rozemuller, A. J., van der Flier, W. M., Scheltens, P.,
van der Vies, S. M., and Hoozemans, J. J. (2014). Altered distribution
of the EphA4 kinase in hippocampal brain tissue of patients with
Alzheimer’s disease correlates with pathology. Acta Neuropathol. Commun.
2:79. doi: 10.1186/s40478-014-0079-9
Shanley, T. P., Vasi, N., Denenberg, A., and Wong, H. R. (2001). The
serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory
cell signaling. J. Immunol. 166, 966–972. doi: 10.4049/jimmunol.166.2.966
Siddiqui, S., Fang, M., Ni, B., Lu, D., Martin, B., and Maudsley, S. (2012).
Central role of the EGF receptor in neurometabolic aging. Int. J. Endocrinol.
2012:739428. doi: 10.1155/2012/739428
Song, F., Chiang, P., Wang, J., Ravits, J., and Loeb, J. A. (2012).
Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. J.
Neuropathol. Exp. Neurol. 71, 104–115. doi: 10.1097/NEN.0b013e31824
23c43
Sontag, J. M., and Sontag, E. (2014). Protein phosphatase 2A dysfunction in
Alzheimer’s disease. Front. Mol. Neurosci. 7:16. doi: 10.3389/fnmol.2014.00016
Stemmer, N., Strekalova, E., Djogo, N., Ploger, F., Loers, G., Lutz, D., et al.
(2013). Generation of amyloid-beta is reduced by the interaction of calreticulin
with amyloid precursor protein, presenilin and nicastrin. PLoS ONE 8:e61299.
doi: 10.1371/journal.pone.0061299
Tuncbag, N., Braunstein, A., Pagnani, A., Huang, S. S., Chayes, J., Borgs, C.,
et al. (2013). Simultaneous reconstruction of multiple signaling pathways
via the prize-collecting steiner forest problem. J. Comput. Biol. 20, 124–136.
doi: 10.1089/cmb.2012.0092
Turei, D., Korcsmaros, T., and Saez-Rodriguez, J. (2016). OmniPath: guidelines
and gateway for literature-curated signaling pathway resources. Nat. Methods
13, 966–967. doi: 10.1038/nmeth.4077
Van Hoesen, G. W., Hyman, B. T., and Damasio, A. R. (1991). Entorhinal
cortex pathology in Alzheimer’s disease. Hippocampus 1, 1–8.
doi: 10.1002/hipo.450010102
Wang, L., Chiang, H. C., Wu, W., Liang, B., Xie, Z., Yao, X., et al. (2012).
Epidermal growth factor receptor is a preferred target for treating amyloid-
beta-induced memory loss. Proc. Natl. Acad. Sci. U.S.A. 109, 16743–16748.
doi: 10.1073/pnas.1208011109
Woodbury, M. E., and Ikezu, T. (2014). Fibroblast growth factor-2 signaling in
neurogenesis and neurodegeneration. J. Neuroimmune Pharmacol. 9, 92–101.
doi: 10.1007/s11481-013-9501-5
Wu, G., Feng, X., and Stein, L. (2010). A human functional protein interaction
network and its application to cancer data analysis. Genome Biol. 11:R53.
doi: 10.1186/gb-2010-11-5-r53
Wyss-Coray, T., and Rogers, J. (2012). Inflammation in Alzheimer disease-a brief
review of the basic science and clinical literature. Cold Spring Harb. Perspect.
Med. 2:a006346. doi: 10.1101/cshperspect.a006346
Yang, H., and Tracey, K. J. (2010). Targeting HMGB1 in inflammation. Biochim.
Biophys. Acta 1799, 149–156. doi: 10.1016/j.bbagrm.2009.11.019
Yuan, X. Z., Sun, S., Tan, C. C., Yu, J. T., and Tan, L. (2017). The role of ADAM10
in Alzheimer’s Disease. J. Alzheimers. Dis. 58, 303–322. doi: 10.3233/JAD-1
70061
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer JEE and handling Editor declared their shared affiliation.
Copyright © 2018 Ravichandran, Michelucci and del Sol. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Physiology | www.frontiersin.org 15 March 2018 | Volume 9 | Article 154
